US FTC sues to block private equity buy of medical company [Yahoo! Finance]
Surmodics, Inc. (SRDX)
Last surmodics, inc. earnings: 4/29 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
surmodics.gcs-web.com/investor-overview
Company Research
Source: Yahoo! Finance
by private equity firm GTCR, saying the deal would contribute to high healthcare costs. The FTC said the deal would give the combined company more than 50% of the market for suppliers of hydrophilic coatings used to smooth surgical and internal medical devices such as catheters. The competition between Surmodics and GTCR portfolio company Biocoat has driven innovation and lowered prices for the product, the FTC said. The merger is the first the FTC has sought to block under President Donald Trump's administration, which has said lowering consumer costs is a priority. FTC Chairman Andrew Ferguson said on social media site X that the merger would have contributed to already high healthcare costs. "The Trump-Vance FTC will work every day
Read more
Impact Snapshot
Event Time:
SRDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRDX alerts
High impacting Surmodics, Inc. news events
Weekly update
A roundup of the hottest topics
SRDX
News
- Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon [Yahoo! Finance]Yahoo! Finance
- Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated BalloonBusiness Wire
- Illinois, Minnesota join FTC challenge against $627M Surmodics buyout [Yahoo! Finance]Yahoo! Finance
- Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries [Yahoo! Finance]Yahoo! Finance
- Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral ArteriesBusiness Wire
SRDX
Earnings
- 5/1/24 - Beat
SRDX
Sec Filings
- 3/21/25 - Form SCHEDULE
- 3/19/25 - Form SCHEDULE
- 3/7/25 - Form 8-K
- SRDX's page on the SEC website